Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine
2024

Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine

publication 10 minutes Evidence: moderate

Author Information

Author(s): Silina Ekaterina V., Manturova Natalia E., Chuvilina Elena L., Gasanov Akhmedali A., Andreeva Olga I., Pugachevskii Maksim A., Kochura Aleksey V., Kryukov Alexey A., Suzdaltseva Yulia G., Stupin Victor A.

Primary Institution: I.M. Sechenov First Moscow State Medical University (Sechenov University)

Hypothesis

The study aims to evaluate the biomedical applications of gadolinium oxide nanoparticles (Gd2O3 NPs) and their effects on human cell lines involved in regeneration.

Conclusion

The study demonstrated the safety and regenerative potential of Gd2O3 nanoparticles, which stimulated fibroblast metabolism and enhanced keratinocyte proliferation, suggesting their use in skin wound healing.

Supporting Evidence

  • Gd2O3 NPs stimulated fibroblast metabolism at a concentration of 10−3 M, enhancing it by 27%.
  • Gd2O3 NPs enhanced keratinocyte proliferation by an average of 35% at concentrations of 10−4 M.
  • The nanoparticles showed weak antioxidant activity at lower concentrations and pro-oxidant activity at higher concentrations.
  • Studies indicated a high level of safety and regenerative potential of Gd2O3 NPs towards different cell lines.

Takeaway

Gadolinium oxide nanoparticles can help heal wounds by making skin cells work better and grow faster without being harmful.

Methodology

The study involved synthesizing Gd2O3 nanoparticles and testing their effects on human fibroblasts, keratinocytes, and mesenchymal stem cells using various assays.

Potential Biases

Potential conflicts of interest due to affiliations with the manufacturing company of the nanoparticles.

Limitations

The study did not explore the long-term effects of Gd2O3 NPs or their behavior in vivo.

Participant Demographics

Human cell lines (fibroblasts, keratinocytes, mesenchymal stem cells) were used in the study.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/pharmaceutics16121627

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication